tiprankstipranks
Trending News
More News >
Santen Pharmaceutical Co Ltd (JP:4536)
:4536
Japanese Market

Santen Pharmaceutical Co (4536) Financial Statements

Compare
0 Followers

Santen Pharmaceutical Co Financial Overview

Santen Pharmaceutical Co's market cap is currently $571.38B. The company's EPS TTM is ¥25.77; its P/E ratio is 16.09; and it has a dividend yield of 2.27%. Santen Pharmaceutical Co is scheduled to report earnings on May 13, 2025, and the estimated EPS forecast is ¥22.98. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 300.00B¥ 301.96B¥ 279.04B¥ 266.26B¥ 249.60B
Gross Profit¥ 162.22B¥ 163.88B¥ 166.09B¥ 156.59B¥ 151.38B
Operating Income¥ 50.15B¥ 38.54B¥ -3.09B¥ 35.89B¥ 12.92B
EBITDA¥ 68.83B¥ 56.46B¥ 14.30B¥ 54.52B¥ 30.01B
Net Income¥ 36.25B¥ 26.64B¥ -14.95B¥ 27.22B¥ 6.83B
Balance Sheet
Cash & Short-Term Investments¥ 93.00B¥ 94.96B¥ 58.68B¥ 84.31B¥ 63.41B
Total Assets¥ 409.28B¥ 435.70B¥ 421.18B¥ 459.98B¥ 402.35B
Total Debt¥ 0.00¥ 35.16B¥ 36.21B¥ 32.93B¥ 10.15B
Net Debt¥ -93.00B¥ -59.42B¥ -21.70B¥ -50.08B¥ -52.74B
Total Liabilities¥ 124.10B¥ 130.33B¥ 127.88B¥ 123.13B¥ 95.30B
Stockholders' Equity¥ 286.24B¥ 306.06B¥ 293.98B¥ 337.49B¥ 307.58B
Cash Flow
Free Cash Flow¥ 54.27B¥ 61.96B¥ 12.56B¥ 10.20B¥ 15.00B
Operating Cash Flow¥ 60.93B¥ 72.65B¥ 37.15B¥ 46.04B¥ 38.81B
Investing Cash Flow¥ -8.22B¥ -6.14B¥ -26.78B¥ -35.17B¥ -53.35B
Financing Cash Flow¥ -53.31B¥ -34.03B¥ -37.22B¥ 5.56B¥ -16.68B
Currency in JPY

Santen Pharmaceutical Co Earnings and Revenue History

Santen Pharmaceutical Co Debt to Assets

Santen Pharmaceutical Co Cash Flow

Santen Pharmaceutical Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis